Innovita Biological Technology Co Ltd Class A 688253
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥37.50
- Day Range
- ¥37.53–39.65
- 52-Week Range
- ¥19.12–47.85
- Bid/Ask
- ¥39.63 / ¥39.64
- Market Cap
- ¥5.39 Bil
- Volume/Avg
- 2.1 Mil / 1.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 19.62
- Price/Sales
- 8.00
- Dividend Yield (Trailing)
- 1.01%
- Dividend Yield (Forward)
- 1.01%
- Total Yield
- 1.01%
Company Profile
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 439
- Website
- https://www.innovita.com.cn
Comparables
Valuation
|
Metric
|
688253
|
688068
|
603392
|
|---|---|---|---|
Price/Earnings (Normalized) | 19.62 | — | 85.49 |
Price/Book Value | 2.70 | 0.77 | 7.57 |
Price/Sales | 8.00 | 4.95 | 34.36 |
Price/Cash Flow | 15.34 | — | 402.76 |
Price/Earnings
688253
688068
603392
Financial Strength
|
Metric
|
688253
|
688068
|
603392
|
|---|---|---|---|
Quick Ratio | 15.40 | 3.29 | 3.81 |
Current Ratio | 15.84 | 6.88 | 4.48 |
Interest Coverage | 2,238.82 | −253.76 | −59.06 |
Quick Ratio
688253
688068
603392
Profitability
|
Metric
|
688253
|
688068
|
603392
|
|---|---|---|---|
Return on Assets (Normalized) | 12.17% | −5.33% | −3.06% |
Return on Equity (Normalized) | 13.13% | −5.67% | −3.76% |
Return on Invested Capital (Normalized) | 12.68% | −6.61% | −4.05% |
Return on Assets
688253
688068
603392
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Zcnthsphz | Vxjh | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Xwlhknmd | Rqqkvx | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Fxkjttv | Gkfdp | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Fwtlmrp | Rhvkwj | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Jmrslnyv | Spzlb | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Xscnhflhq | Lktmc | $28.1 Bil | |||
| Moderna Inc
MRNA
| Fqjfwldj | Btds | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Zmpqjqwpw | Cvdqr | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Sftxqrfj | Cmlrfd | $13.4 Bil | |||
| Incyte Corp
INCY
| Tlddrnmkg | Ptbxylf | $12.7 Bil |
United States